Get started
Author

Paolo Cozzolino

Observed names: Cozzolino, P, P Cozzolino, P. Cozzolino
ORCID: 0000-0001-6178-8581
Observed ORCID: 0000-0001-6178-8581
OpenAlex ID: A5015286723
Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery
2017 · Paolo A. Cortesi, Roberto Assietti, et al. · Spine · 42
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting
2018 · Luciana Scalone, Furio Zucco, et al. · Health and Quality of Life Outcomes · 34
PDF
Effects of extracorporeal cardiopulmonary resuscitation on neurological and cardiac outcome after ischaemic refractory cardiac arrest
2017 · Francesca Cesana, Leonello Avalli, et al. · European Heart Journal Acute Cardiovascular Care · 33
Occupational Exposure in the Lombardy Region (Italy) to SARS-CoV-2 Infection: Results from the MUSTANG–OCCUPATION–COVID-19 Study
2021 · Paola Della Valle, Marco Fabbri, et al. · International Journal of Environmental Research and Public Health · 25
PDF
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey
2023 · Arianna Fornari, Ippazio Cosimo Antonazzo, et al. · Haemophilia · 15
PDF
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry
2018 · Jean-Yves Le Heuzey, Jean-Pierre Bassand, et al. · Archives of cardiovascular diseases · 14
PDF
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view
2022 · Paolo Angelo Cortesi, Angiola Rocino, et al. · Haemophilia · 11
Peripheral arterial disease in diabetic patients: a long-term population-based study on occurrence, outcomes and cost
2018 · Enrico M. Marone, Paolo Cozzolino, et al. · The Journal of Cardiovascular Surgery · 10
The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis
2019 · Paolo Angelo Cortesi, Damiano Paolicelli, et al. · Farmeconomia Health economics and therapeutic pathways · 9
PDF
Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression Study
2022 · Paolo A. Cortesi, Carla Fornari, et al. · Value in Health · 8
PDF
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis
2020 · the SA.FE. study group, Lorenzo G. Mantovani, et al. · Clinical Drug Investigation · 7
Clinical outcome indicators in chronic hepatitis B and C: A primer for value‐based medicine in hepatology
2019 · Mario Strazzabosco, Paolo A. Cortesi, et al. · Liver International · 6
PDF
The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases
2020 · Paolo Angelo Cortesi, Paolo Cozzolino, et al. · Farmeconomia Health economics and therapeutic pathways · 5
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients
2023 · Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, et al. · Medicina · 4
PDF
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
2023 · Lorenzo G. Mantovani, Paolo Cozzolino, et al. · Healthcare · 4
PDF
P2889The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry
2018 · P Cozzolino, G Ambrosio, et al. · European Heart Journal · 3
The Prevalence and Treatment Status of Different Multiple Sclerosis Phenotypes in a Italian Reference Center
2017 · PA Cortesi, P Cozzolino, et al. · Value in Health · 3
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases
2014 · P.A. Cortesi, M. Rota, et al. · Value in Health · 3
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life
2013 · P.A. Cortesi, L. Scalone, et al. · Value in Health · 3
Health Related Quality of Life in the Major Liver Conditions
2013 · Paolo Angelo Cortesi, L Scalone, et al. · BOA (University of Milano-Bicocca) · 3
Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens
2019 · T. Schioppo, L. Scalone, et al. · Reumatismo · 2
PDF
The Economic Burden of Different Multiple Sclerosis Phenotypes
2017 · P Cozzolino, PA Cortesi, et al. · Value in Health · 2
Economic Burden Of Stroke: Analysis From An Administrative Database
2014 · R Ciampichini, P Cozzolino, et al. · Value in Health · 2
The impact of liver disease on the health-related quality of life
2014 · Paolo Angelo Cortesi, M. Rota, et al. · BOA (University of Milano-Bicocca) · 2
PDG15 Evolution of Natalizumab Use in Two Italian Multiple Sclerosis Centers
2020 · P. Cozzolino, P.A. Cortesi, et al. · Value in Health · 1
Works count: 48
Citation count: 254
H-index: 9
I10-index: 8
Year
Topic
Type